차바이오텍, 차헬스케어 지분 매각…차원태표 'BD 재편' 실험 연장선

CHABiotech's strategic stake sale in CHA Healthcare marks a pivotal shift from partnership formation to aggressive commercialization within its global healthcare and AI ecosystem. This move provides essential liquidity to manage rising debt while accelerating the integration of CGT, CDMO, and digital health platforms. The restructuring highlights a 'select and focus' strategy aimed at transforming medical data and hospital networks into tangible revenue-generating business models.